SCHEMBL22739004

SCHEMBL22739004

CCC(CC)CCC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OCC(CC)CC)OC[C@@H]1CC[C@](C#N)(c2ccc3c(N)ncnn23)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096277 0.95 AXL (0.30) —
SCHEMBL22393573 0.87 TMPRSS2 (0.32) —
SCHEMBL24148708 0.85 CYP3A4 (0.32) —
SCHEMBL22739060 0.85 TMPRSS2 (0.40) —
SCHEMBL18636608 0.85 CYP3A4 (0.32) —
SCHEMBL22739002 0.83 KRAS (0.31) —
SCHEMBL25012912 0.82 CSNK1A1 (0.31) —
SCHEMBL18636474 0.82 TMPRSS2 (0.31) —
SCHEMBL25012546 0.82 — —
SCHEMBL10142401 0.79 TMPRSS2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200376014-A1 METHODS OF TREATING FELINE CORONAVIRUS INFECTIONS GILEAD SCIENCES, INC. 2020-12-03 — — US disclosed
Send feedback